News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antibacterial Biotech Achaogen Sets Terms For $65 Million IPO


2/25/2014 7:39:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Achaogen, which is developing antibacterials for the treatment of multi-drug resistant infections, announced terms for its IPO on Tuesday. The South San Francisco, CA-based company plans to raise $65 million by offering 5 million shares at a price range of $12 to $14.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
Achaogen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES